Feriandas Greblikas
About Feriandas Greblikas
Feriandas Greblikas serves as the Senior Medical Director and Fosmetpantotenate Program Lead at Travere Therapeutics, a position he has held since 2017. He has extensive experience in the pharmaceutical industry, having worked in various roles at companies such as Baxter International, Merck Sharp & Dohme, and Biogen Idec.
Work at Travere Therapeutics
Feriandas Greblikas serves as the Senior Medical Director and Fosmetpantotenate Program Lead at Travere Therapeutics. He has held this position since 2017, contributing to the development and management of the Fosmetpantotenate program. His role involves overseeing clinical strategies and ensuring alignment with regulatory requirements. Based in the Greater San Diego Area, Greblikas plays a key role in advancing therapeutic options for patients.
Previous Experience in Clinical Research
Before joining Travere Therapeutics, Greblikas worked at Baxter International Inc. as Associate Medical Director in Global Clinical Research for Hematology and Hemophilia from 2013 to 2014. He also held the position of Medical Director at BioMarin Pharmaceutical Inc. from 2015 to 2017. His experience includes significant roles in clinical research and development across various pharmaceutical companies.
Educational Background
Feriandas Greblikas studied at Vilnius University, where he earned a Doctor of Medicine (MD) degree from 1984 to 1991. He also attended the International School of Business at Vilnius University, achieving an Economist qualification in Pharmaceuticals from 1998 to 2000. This educational foundation supports his extensive career in the medical and pharmaceutical sectors.
Career Path in the Pharmaceutical Industry
Greblikas has held various positions in the pharmaceutical industry, including roles at Merck Sharp & Dohme as a Business Unit Manager from 2004 to 2006, and at Biogen Idec as Associate Director of Medical Research from 2011 to 2013. His career also includes significant positions at Novo Nordisk, Bristol-Myers Squibb, and AstraZeneca, where he contributed to product management and medical affairs.